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Context: Elevated human choriogonadotropin (hCG) may stimulate aberrantly expressed luteinizing
hormone (LH)/hCG receptor (LHCGR) in adrenal glands, resulting in pregnancy-induced bilateral
macronodular adrenal hyperplasia and transient Cushing syndrome (CS).
Objective: To determine the role of LHCGR in transient, pregnancy-induced CS.
Design, Setting, Patient, and Intervention:We investigated the functional implications of LHCGRs
in a patient presenting, at a tertiary referral center, with repeated pregnancy-induced CS with bilateral
adrenal hyperplasia, resolving after parturition.
Main Outcome Measures and Results: Acute testing for aberrant hormone receptors was negative
except for arginine vasopressin (AVP)–increased cortisol secretion. Long-term hCG stimulation induced
hypercortisolism, which was unsuppressed by dexamethasone. Postadrenalectomy histopathology demon-
strated steroidogenically active adrenocortical hyperplasia and ectopic cortical cell clusters in the medulla.
Quantitative polymerase chain reaction showed upregulated expression of LHCGR, transcription factors
GATA4, ZFPM2, and proopiomelanocortin (POMC), AVP receptors (AVPRs) AVPR1A and AVPR2, and
downregulated melanocortin 2 receptor (MC2R) vs control adrenals. LHCGR was localized in subcapsular,
zona glomerulosa, and hyperplastic cells. Single adrenocorticotropic hormone–positive medullary cells were
demonstrated in the zona reticularis. The role of adrenal adrenocorticotropic hormone was considered
negligible due to downregulated MC2R. Coexpression of CYP11B1/CYP11B2 and AVPR1A/AVPR2 was
Abbreviations: ACTH, adrenocorticotropic hormone; APA, aldosterone-producing adenoma; AVP, arginine vasopressin; AVPR, arginine
vasopressin receptor; BMAH, bilateral macronodular adrenal hyperplasia; cAMP, cyclic adenosine monophosphate; CRH,
corticotropin-releasing hormone; CS, Cushing syndrome; GA, gestational age; GATA4, GATA binding protein 4; GnRH, gonadotropin-
releasing hormone; hCG, human choriogonadotropin; LH, luteinizing hormone; LHCGR, luteinizing hormone/human choriogona-
dotropin receptor; MC2R, melanocortin 2 receptor; mRNA, messenger RNA; POMC, proopiomelanocortin; qPCR, quantitative
polymerase chain reaction.
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observed in ectopic cortical cells in the medulla. hCG stimulation of the patient’s adrenal cell cultures sig-
nificantly increased cyclic adenosine monophosphate, corticosterone, 11-deoxycortisol, cortisol, and andros-
tenedione production.CTNNB1,PRKAR1A,ARMC5, andPRKACA genemutational analyseswere negative.
Conclusion: Nongenetic, transient, somatic mutation-independent, pregnancy-induced CS was due to
hCG-stimulated transformation of LHCGR-positive undifferentiated subcapsular cells (presumably
adrenocortical progenitors) into LHCGR-positive hyperplastic cortical cells. These cells respond to hCG
stimulation with cortisol secretion. Without the ligand, they persist with aberrant LHCGR expression
and the ability to respond to the same stimulus.
Copyright © 2017 by the Endocrine Society
This article has been published under the terms of the Creative Commons Attribution License (CC
BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
Freeform/Key Words: Cushing’s syndrome, BMAH, adrenal hyperplasia, LHCGR, pregnancy,
GATA-4
Primary bilateral macronodular adrenal hyperplasia (BMAH) causes ,1% of endogenous
Cushing syndrome (CS), although subclinical cortisol production occurs more frequently [1]. In
BMAH several G protein–coupled receptors have been shown to be aberrantly expressed in the
adrenal cortex and to induce adrenal steroid synthesis, cellular proliferation, and/or adrenal
hyperplasia [2–4]. These include receptors for gastric inhibitory polypeptide, arginine vaso-
pressin (AVP), serotonin, catecholamines, and luteinizing hormone (LH)/human choriogona-
dotropin (hCG). Ligand-induced receptor activation results in cortisol excess and suppression of
pituitary adrenocorticotropic hormone (ACTH) secretion; however, stimulated secretion of
ACTH locally produced in clusters of BMAH cells has been described as well [5–9].
In pregnancy-induced CS, ectopic adrenal LH/hCG receptor (LHCGR) expression has been
related to hypercortisolism, hyperandrogenism, and hyperaldosteronism [10, 11]. Physio-
logically increased hCG secretion during pregnancy may affect the expression of LHCGR,
adrenal cell differentiation, and zonal distribution [9, 12]. It has been suggested that LHCGR
activation upregulates the expression of the transcription factor GATA binding protein 4
(GATA4), which asmodulated by zinc finger protein ZFPM2 is essential for adrenocortical cell
neoplastic differentiation and proliferation [12–14]. GATA4 is upregulated in murine and
human adrenocortical tumors [12–14].
Somatic mutations in the CTNNB1, PRKAR1A, ARMC5, and PRKACA genes have been
found in pregnancy/menopause-induced aldosterone-producing adenomas (APAs) [11], pri-
mary pigmented nodular adrenocortical disease [15], familial BMAH [16], and cortisol-
producing adrenocortical adenomas [17], respectively.
In this study, we describe novel features of gene expression in LHCGR-mediated,
pregnancy-induced, mutation-independent (or nongenetic), transient CS, which elucidate
the molecular pathogenesis of this rare condition of adrenocortical hyperplasia.
1. Materials and Methods
A. Diagnostic Procedures
CS was diagnosed by determinations of ACTH, steroid hormones, 24-h urinary cortisol,
dexamethasone suppression, aberrant hormone receptor testing, and long-term stimulation
with hCG (see details in the Supplemental Appendix).
B. Morphological, Histopathological, Molecular, and Biochemical Investigations
Following bilateral adrenalectomy, the patient’s adrenal tissues were investigated by histopa-
thology,RNAscope in situhybridization, geneexpressionprofilingbyquantitativepolymerase chain
reaction (qPCR) (SupplementalTable1), immunohistochemical localizationanalysis (Supplemental
Table 2A and 2B), and gene mutation analysis for CTNNB1, PRKAR1A, and ARMC5. Primary
58 | Journal of the Endocrine Society | doi: 10.1210/js.2016-1021
adrenal cells were stimulated with ACTH and recombinant hCG. Tandemmass spectroscopy and
radioimmunoassay were used for steroid hormone and extracellular cyclic adenosine mono-
phosphate (cAMP) determination, respectively (see details in the Supplemental Appendix).
2. Results
A. Case Report
A 22-year-old primigravid woman at 21 weeks gestational age (GA) presented with signs
and symptoms of CS (Fig. 1). The increased 24-hour urinary free cortisol excretion,
Figure 1. Pregnancy induced CS: clinical symptoms, timeline, computed tomography, and
histology. Pregnancy-induced CS (A). A 22-year-old pregnant woman (gravida 1, 21 weeks
GA) presented with arterial hypertension, diabetes mellitus, acne (A; black arrow), hirsutism,
edema, purple striae distensae (stretch marks) (A; black arrows), and moon face. (B)
Schematic timeline view from diagnosis to bilateral adrenalectomy (ADX). (C and D)
Abdominal computed tomography and adrenal volumetry showed bilateral enlarged adrenals
that normalized after parturition. (E–G) Histopathology with hematoxylin and eosin staining
of right adrenal (E) showed hyperplasia with large spongiocytic lipid-loaded cells of the
adrenal cortex (F) and clusters of small compact ectopic cortical cells infiltrating the medulla
(G). Scale bars, 1000 mm (E) and 50 mm (F and G).
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nonsuppressability of cortisol by dexamethasone, low plasmaACTH concentration [,5 pg/mL
(,1.1 nmol/L)] (Tables 1–3), and unresponsiveness to corticotropin-releasing hormone (CRH)
suggested ACTH-independent CS. The family history was negative for endogenous hyper-
cortisolism. Computed tomography showed bilaterally enlarged adrenals, but no nodular
structures [Fig. 1(C) and 1(D)]. Acne suggesting hyperandrogenism (Fig. 1(A); Supplemental
Table 3], insulin-dependent diabetes mellitus, and hypokalemic hypertension were prom-
inent. At 25 weeks GA, preterm labor resulted in the vaginal delivery of a male child (sex
chromosomes XY) [Fig. 1(B)]. The child died on day 3 due to septicemia and pulmonary
hemorrhage. Within a week after delivery, the signs and symptoms of CS receded. Two weeks
postpartum, peripheral and adrenal vein aldosterone concentrations were still suppressed
[aldosterone, 2.3 ng/mL (,63.8 pmol/L); normal range supine, 2.3 to 16 ng/mL (63.8 to 440.0
pmol/L)] and did not increase after ACTH stimulation. Biochemical changes and adrenal
volume had normalized 49 days after parturition (Table 3; Fig. 1(C) and 1(D)]. During ab-
errant hormone receptor testing, 19 weeks postpartum ACTH-stimulated cortisol secretion
was normal (Table 2; Supplemental Table 4). Orthostasis, a standard meal, thyrotropin-
releasing hormone injections, gonadotropin-releasing hormone (GnRH) injections, glucagon
injections, or oral metoclopramide failed to evoke a positive cortisol response. However, AVP
injection induced a 30-fold increase in cortisol, albeit at a low basal plasma cortisol con-
centration due to the preceding dexamethasone administration (Table 2; Supplemental
Table 4). Long-term hCG stimulation resulted in a peak plasma hCG concentration of 809 IU/
L (day 6, hCG 10,000 IU/d), representing 3.2% of the hCG concentration at 26 weeks GA. The
peak plasma cortisol concentration increased to 144% [15.1 to 21.7mg/dL (386.4 to 555.2 nmol/
L)] at day 2 on hCG 5000 IU/d and 133% [16.0 to 21.3 mg/day (409.4 to 545.0 nmol/L)] at day 2
on hCG 10,000 IU/d, whereas ACTH was suppressed from 11.0 pg/mL to ,5 pg/mL (2.4
to,1.2 nmol/L) at day 2 on hCG 5000 IU/d. hCG stimulation elicited a significant increase in
androgen concentration (Table 3). During hCG stimulation (10,000 IU/d), both cortisol and
Table 1. Differential Diagnosis of CS
Diagnosis of CS

















Normal rangea 9.2–23.7 11.8–485.6 ,46.0 9.2–23.7 11.8–485.6 ,46.0
Day 0 — 13,799.0 ,5.0 — 91.0 11.0
Day 1 44.9 — ,5.0 23.2 — —
CRH test
10:00 AM 38.7 — ,5.0 10.0 — —
10:15 AM 43.8 — ,5.0 15.1 — —
10:30 AM 44.2 — ,5.0 18.0 — —
10:45 AM 40.6 — ,5.0 17.7 — —
11:00 AM 41.0 — ,5.0 18.1 — —
DEXA, 1mg, 12:00 PM
Day 2: 8:00 AM 43.3 — ,5.0 2.8 — ,5.0
DEXA, 8mg, 12:00 PM
Day 3: 8:00 AM 48.9 13,089.0 ,5.0 1.2 9.8 ,5.0
DEXA, 3 3 8 mgb
Day 4: 8:00 AM 47.2 11,715.0 6.0 1.1 10.0 ,5.0
Adexamethasonesuppression test,CRHtest,and24-hoururinary free cortisoldeterminationatweek22of the firstpregnancy
and 49 days after spontaneous parturition were used for the diagnosis of Cushing Syndrome. Plasma cortisol concentration
after 1 mg dexamethasone . 1.8 mg/L confirms endogenous, autonomous cortisol secretion. Twenty-four–hour urinary free
cortisol excretion is 28-fold of the upper limit of normal and 4.7-fold of the concentration reported in pregnancy with CS.
Abbreviation: DEXA, dexamethasone.
aAll normal values refer to basal concentrations in nonpregnant females, as normal values for pregnant females are
not available.
bDexamethasone (8 mg) was given 3 times at 8:00 AM, 4:00 PM, and 12:00 PM.
60 | Journal of the Endocrine Society | doi: 10.1210/js.2016-1021
androgen secretions were unresponsive to dexamethasone suppression (Table 3), indicating
hCG-induced CS and hyperandrogenism.
At week 51 [Fig. 1(B)] the patient presented with renewed signs and symptoms of CS,
including an increased 24-hour urinary free cortisol excretion [999.4 mg/24 h (2757 nmol/d);
upper limit of normal, 176 mg/24 h (485.6 nmol/d)] and a concurrent plasma hCG concen-
tration of 2634 IU/L. An ectopic pregnancy was diagnosed and terminated. Thereafter, both
urinary free cortisol excretion and hCG normalized. Four weeks later [Fig. 1(B)] the patient
underwent bilateral adrenalectomy at her request to achieve a normal pregnancy. Thirty
months after the initial diagnosis the patient delivered, after an uneventful pregnancy with
physiologically substituted glucocorticoid and mineralocorticoid replacement therapy, a
healthy female baby.
Table 3. Long-Term bhCG Stimulation
Long-Term bhCG
Stimulation










(IU/L) LH (IU/L)a T (ng/mL)
Normal rangeb 9.2–23.7 11.8–485.6 ,46.0 ,5 2.4–12.6 0.012–0.099
bhCG, 5000 IU/d
(day 1 to day 5)
Day 1 15.1 — 11.0 0.6 5.9 0.01
Day 5 21.5 — ,5.0 399.5 4.7 0.07
bhCG, 10,000 IU/d
(day 1 to day 11)
Day 1 16.0 — ,5.0 123.2 — 0.08
Day 8 19.8 — ,5.0 809.1 — 0.13
After DEXA, 1 mg, 12:00 PM Day 9 21.4 — ,5.0 661.7 — 0.12
Aafter DEXA, 1 mg, 12:00 PM Day 10 20.5 — ,5.0 706.0 — 0.11
After DEXA, 3 3 8 mgc Day 11 20.1 750.0 ,5.0 536.0 — 0.11
Long-term stimulation with hCG (Predalon®) after parturition (week 19): plasma cortisol, ACTH, and hCG con-
centration, as well as results of the dexamethasone suppression test during hCG stimulation, are shown. Daily
injections included 5000 IU of hCG for 5 days and 10,000 IU of hCG for 13 days. Plasma cortisol concentration (8:00
AM) is indicated before the first injection of 5000 IU of hCG, on the last day on 5000 IU of hCG, on the first day of 10,000
IUof hCG, after 8 days of 10,000 IUof hCG, and for 3 days on 10,000 IU of hCGduring the dexamethasone suppression
test.
Abbreviation: DEXA, dexamethasone.
aNormal range for the follicular phase of the menstrual cycle.
bAll normal values refer to basal concentrations in nonpregnant females, as normal values for pregnant females are
not available.
cDexamethasone (8 mg) was given 3 times at 8:00 AM, 4:00 PM, and 12:00 PM.
Table 2. Acute In Vivo Tests for Aberrant Receptors





Maximum (mg/dL) % Increase
Orthostasis 10.8 13.9 28.7
Test meal 5.8 8.6 48.3
ACTH, 0.25 mg intramuscularly 9.2 22.4 143.5
GnRH, 200 mg intravenously 18.2 16.3 210.4
Thyrotropin-releasing hormone, 200 mg
intravenously
5.0 7.2 44.0
Glucagon, 1 mg intramuscularly 5.6 7.0 25.0
DEXA, 0.5 mg orally/AVP, 10
IE intramuscularly
0.1 3.1 3000.0
Metoclopramide, 10 mg orally 1.1 1.2 9.1
Results of standardized in vivo screening tests for the presence of ectopic or overexpressed eutopic adrenal hormone
receptors in the patient with CS are shown. Responses to the various stimuli were considered “positive” if there was
a cortisol increase.50% of basal, “partial” with a response between . 25% and , 50%, and “negative” when ,25%.
Abbreviation: DEXA, dexamethasone.
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B. Analysis of Functional Mechanism
Histopathology demonstrated adrenocortical hyperplasiawith large lipid-loaded spongiocytic
cells [Fig. 1(E) and 1(F)] and few clusters of small compact cells in the center of the medulla
[Fig. 1(E) and 1(G)] resembling zona reticularis cells.
The LHCGRmessenger RNA (mRNA) expression was fourfold upregulated compared with
normal healthy female adrenal tissue [Fig. 2(A)]. LHCGRmRNAand proteinwere colocalized
in the undifferentiated subcapsular cells of the cortex [Fig. 2(B) and (E)], in zona glomerulosa
cells [Fig. 2(C) and (E)], and in hyperplastic cells [Fig. 2(E) and 2(F); Supplemental Fig. 1].
ACTH or rhCG stimulation of isolated adrenal cells increased cAMP production by 158.6%
(P = 0.048) or 25.4% (P = 0.011), respectively, vs nonstimulated cells [Fig. 2(G)], confirming the
suggested transduction pathway for LHCGR. ACTH and rhCG stimulation of dispersed and
cultured adrenal cells induced a significant increase in corticosterone, 11-deoxycortisol,
cortisol, and androstenedione production in accordance with the positive in vivo response of
cortisol and testosterone to long-term hCG stimulation [Fig. 2(H); Table 3].
In parallel to the upregulation of the LHCGR expression, GATA4 and the modulator of its
transcriptional activity ZFPM2 were upregulated at the mRNA level vs control [Fig. 3(A);
eightfold and 2.8-fold, respectively]. However, although immunohistochemistry demon-
strated LHCGR in undifferentiated subcapsular cells of the cortex and zona glomerulosa and
in hyperplastic cells (see above), only GATA4 was observed within the undifferentiated
subcapsular cells [Fig. 3(B)], whereas both GATA4- and ZFMP2-positive cells were positive in
the zona glomerulosa cells [Fig. 3(C) and 3(F)]. In contrast, the hyperplastic cells of the cortex
were negative for both GATA4 and ZFPM2 expression [Fig. 3(D) and 3(G)].
The steroidogenic profiles of the hyperplastic cortical cells and the ectopic cortical cells in
the medulla were defined by immunofluorescence localization of CYP11A1, 3b-HSD,
CYP21A1, CYP17, CYP11B1, and CYP11B2 (Fig. 4). The hyperplastic cells expressed all
steroidogenic enzymes except CYP11B2 [Fig. 4(A–F)], whereas the ectopic cortical cells in the
medulla coexpressed both CYP11B1 and CYP11B2 [Fig. 4(L)]. The cortical phenotype of the
cell clusters in themedulla was demonstrated by positive staining for all cortical cell markers
analyzed and by negative staining for the medullary cell marker chromogranin A [CgA; Fig.
4(G)].
mRNA expression of the ACTH precursor POMC and the two AVP receptors (AVPRs)
AVPR1A and AVPR2 was highly upregulated in both adrenals vs the healthy female controls
[Fig. 5(A)]. Immunohistochemistry demonstrated ACTH-positive cells only in CgA-positive
adrenal medullary cells, located adjacent to the zona reticularis [Fig. 5(B); Supplemental
Figs. 2 and 3]. ACTH receptor [melanocortin 2 receptor (MC2R)] expression was down-
regulated [Fig. 5(A)]. As expected, immunohistochemistry localized the MC2R mainly in the
cells of the zona fasciculata and reticularis (Fig. 5C; Supplemental Fig. 4). Quite un-
expectedly, AVPR1A andAVPR2were found in the ectopic cortical cell clusters in themedulla
(Fig. 5(D) and 5(E); Supplemental Figs. 5 and 6). Vasopressin was not expressed in the
patient’s adrenals (Supplemental Fig. 7). All findings are summarized in Supplemental
Table 5. CTNNB1, PRKAR1A, ARMC5, and PRKACA gene mutational analyses were
negative.
3. Discussion
Diagnosing excess cortisol secretion in pregnancy is challenging due to the physiological
modification of the ACTH/cortisol axis by the placental production of CRH and ACTH [18].
However, in our patient the diagnostic confidence was high, due to the convincing signs and
symptoms of CS and the clearly elevated urinary free cortisol concentrations. The suppressed
plasma ACTH concentration indicated primary adrenal hypercortisolism [18]. The clinical
course of the pregnancy followed the established risk of maternal morbidity and adverse fetal
outcome in untreated CS [19–23]. The postpartum remission of CS after the first normal and
the second extrauterine pregnancy suggested transient pregnancy-induced hypercortisolism
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Figure 2. Expression, cellular localization, and functionality of adrenal LHCGR. (A)
Quantification of LHCGR mRNA expression in the patient’s left and right adrenal (ADR) and
in an adrenal of a female healthy control subject by qPCR. Data are normalized to four
housekeeping genes: cyclophilin A (PPIA), b-actin (ACTB), b-glucuronidase (GUSB), and 18S
ribosomal RNA (18S rRNA) and presented as fold change where expression of control group
is equal to 1.0 (bar not shown on the graph); controls, n = 3. (B–D) LHCGR RNA in situ
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related to hCG secretion and was subsequently confirmed to be due to the increased ex-
pression of eutopic adrenal LHCGR [21] and hCG-stimulated steroidogenesis [4, 8]. To
identify the receptors responsible for aberrant cortisol secretion, a standardized acute in vivo
screening procedure [24] was performed after parturition [Fig. 1(B)]. At the time of testing,
the 8:00 AM ACTH concentration was rather low, suggesting a still incomplete recovery of the
ACTH/cortisol axis from hypercortisolism after parturition. Alternatively, the corresponding
basal and ACTH-stimulated cortisol concentrations were normal, indicating normal adrenal
function.
hybridization (RNAscope®) in subcapsular cells (B), zona glomerulosa (C), and hyperplastic
cells (D). (E and F) Immunohistochemical localization of LHCGR in subcapsular (arrowhead),
zona glomerulosa (E, arrows), and hyperplastic cells (F, arrows). Sections were
counterstained with hematoxylin. Scale bars, 10 mm. (G) Recombinant hCG-stimulated cAMP
production and (H) 11-deoxycorticosterone, 11-deoxycortisol, corticosterone, cortisol, and
androstenedione secretion in the primary adrenal cells isolated after adrenalectomy. *P ,
0.05, ***P , 0.001. C, adrenal capsule; HC, hyperplastic cell; rhCG, recombinant hCG; ZF,
zona fasciculata; ZG. zona glomerulosa.
Figure 3. Expression and cellular localization of adrenal GATA4 and ZFMP2. (A) Quantification
of GATA4 and ZFMP2 mRNA expression in the patient’s left and right adrenal (ADR) and in an
adrenal of a female healthy control subject by qPCR. Data are normalized to four housekeeping
genes: cyclophilin A (PPIA), b-actin (ACTB), b-glucuronidase (GUSB), and 18S ribosomal RNA
(18S rRNA). Results are presented as fold change where expression of control group is equal to
1.0 (bar not shown on the graph); controls, n = 3. (B–G) Immunohistochemical localization of
GATA4 (B–D) and ZFMP2 (E–G) in the adrenal gland of the patient. GATA4 was localized in
subcapsular (B) and zona glomerulosa cells (C) (black arrows), whereas ZFMP2 was detected only
in zona glomerulosa cells (F) (black arrows). Subcapsular cells (black arrows) were negative for
ZFMP2 (E). Hyperplastic cells of the adrenal gland were negative for both GATA4 (D) and
ZFMP2 (G). Sections were counterstained with hematoxylin. Scale bars, 10 mm. C, adrenal
capsule; HC, hyperplastic cell; ZG, zona glomerulosa.
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Figure 4. Origin and steroidogenic profile of hyperplastic cells and ectopic cortical cells in
the medulla by immunofluorescence staining. (A–F) Immunofluorescence localization of
CYP11A1 (red, A); 3bHSD (green, B); CYP21 (green, C); CYP17 (green, D), CYP11B1 (red, E),
and CYP11B2 (red, F) in the cells of adrenal hyperplasia and normal cortical cells of zona
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The acute GnRH stimulation during initial in vivo testing failed to elicit a cortisol increase,
possibly in part due to the postpartum still-unresponsive endogenous LH secretion. However,
after long-term hCG stimulation, even though hCG plasma concentration was significantly
lower than during the first trimesters of both pregnancies, symptomatic and dexamethasone
nonsuppressible hypercortisolism and hyperandrogenism were observed. Thus, outside
pregnancy, long-term stimulation is probably a prerequisite for this positive response, and the
monthly preovulatory LH surge is obviously too short to induce the syndrome. Post-
adrenalectomy (4 weeks after termination of the second, ectopic pregnancy) gene expression
studies on the removed adrenal tissue demonstrated persistently upregulated LHCGR, lo-
calized in sparsely distributed undifferentiated subcapsular cells, in glomerulosa cells, and in
hyperplastic zona fasciculata–type BMAH cells. The LHCGR-positive subcapsular cells may
belong to a pool of progenitor cells with a capacity to develop into gonadal-like and/or ad-
renocortical cells. It is known that both the adrenal cortex and the gonads originate from a
common stem/progenitor cell population in the adrenogenital ridge. Owing to mistrafficking,
some of the stem/progenitor cells, directed into gonadal differentiation,migrate to the adrenal
compartment. There, under specific conditions, they may differentiate into mixed
gonadotropin/steroid-responsive gonadal-like cells with adrenocortical phenotype [25, 26].
We suggest that under persistently high LH/hCG stimulation these cells may transform into
LH/hCG-responsive glomerulosa-type cells and further give rise to the hyperplastic zona
fasciculata–type BMAH cells.
hCG stimulation of cultured primary adrenal cells obtained after adrenalectomy activated
the adenylyl cyclase pathway and significantly increased the production of glucocorticoids,
androgens, and corticosterone, yet failed to increase aldosterone. Thus, the expression of the
LHCGR in zona glomerulosa cells and hyperplastic cells together with the in vitro data
substantiate the role of the LH/hCG–LHCGR complex in the pathophysiology of pregnancy-
induced CS with hypertension [13], signs and symptoms of glucocorticoid excess, and severe
hyperandrogenism and acne.
Mouse strains and domestic ferrets susceptible to gonadectomy-induced adrenocortical
tumorigenesis develop, under the influence of high LH concentrations, sex steroid–producing
adrenocortical tumors composed of large lipid-loaded LHCGR-positive cells. This phenom-
enon is thought to reflect a gonadotropin-induced neoplastic transformation of stem/
progenitor cells in the subcapsular region of the adrenal gland [27–29]. This trans-
formation is regulated by GATA4, which, together with cofactors ZFMP2 and SF1, is involved
in sex determination, gonadal development, and function [28]. Although GATA4 is not
normally expressed in adult adrenals, it has been reported to play a role in adrenal tu-
morigenesis [14, 30]. UpregulatedGATA4 and ZFMP2, as well as GATA4, LHCGR-matching
localizations in the periphery, and zona glomerulosa cells, may contribute to the neoplastic
development of the LH/hCG-responsive cells. We therefore suggest that increased hCG se-
cretion during pregnancy upregulated LHCGR, GATA4, and ZFMP2 expression and induced
the hCG-responsive subcapsular cells to differentiate into adrenal steroid-producing hy-
perplastic cells. The transformed hyperplastic cells no longer express GATA4 and ZFMP2, as
glomerulosa, zona fasciculata, or zona reticularis. (G–L) Steroidogenic characterization of
ectopic cortical cells infiltrating the medulla by immunofluorescence colocalization (pink or
orange) of 3bHSD (red) used as an adrenocortical cell marker, with CYP11A1 (white, G) and
CgA (green, G), CYP21 (green, H), CYP17 (green, I), CYP11B1 (green, J), and CYP11B2
(green, K). In contrast to normal or hyperplastic cells, cortical cells in the medulla
coexpressed (orange) CYP11B1 (red) and CYP11B2 (green) (L). DAPI was used as
counterstaining to detect cell nuclei (blue). Scale bars, 20 mm. CYP11A1 is a C27 side-chain
cleavage enzyme; CYP11B1, steroid 11-hydroxylase; CYP11B2, steroid 11-b-hydroxylase
(aldosterone synthase); CYP17A1, steroid 17-a-hydroxylase; CYP21, steroid 21-hydroxylase;
and 3bHSD is a 3-b-hydroxysteroid dehydrogenase. CC, ectopic cortical cell in the medulla,
HC, hyperplastic cell; M, adrenal medulla; ZF, zona fasciculate; ZG, zona glomerulosa; ZR,
zona reticularis.
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Figure 5. Adrenal expression and cellular localization of POMC/ACTH, MC2R, AVPR1A,
and AVPR2. (A) Quantification of POMC, MC2R, AVPR1A, and AVPR2 mRNA expression in
the patient’s left and right adrenal (ADR) and in the adrenal of a female healthy control
subject by qPCR. Data are normalized to four housekeeping genes: cyclophilin A (PPIA),
b-actin (ACTB), b-glucuronidase (GUSB), and 18S ribosomal RNA (18S rRNA) and presented
as fold change where expression of control group is equal to 1.0 (bar not shown on the graph);
controls, n = 3. (B–E) Immunofluorescence colocalization (orange, white arrows) of (B) ACTH
(red) with CgA (green) in adrenal medulla on the border with zona reticularis specified by
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they developed an adrenocortical phenotype with a pattern of steroidogenic profile akin to the
zona fasciculata.
Negative results of familial and somatic CTNNB1, PRKACA, ARMC5, and PRKACA
gene mutation analyses excluded a genetic background of CS in our patient [11, 16, 17].
Nevertheless, our patient displayed some similarities with patients who presented with
pregnancy/menopause-induced primary hyperaldosteronism due to a somatic mutation
in CTNNB1 and b-catenin activation [11]. In both cases there were increased hCH/LH
levels, overexpression of LHCGR, and GATA4 positivity in the zona glomerulosa cells.
In the CTNNB1 mutation case, the authors postulated hyperaldosteronism as a con-
sequence of aberrant gonadal differentiation caused by b-catenin activation through a
mutation in CTNNB1 [11]. Very recently, two independent groups have criticized as-
sociation between activated mutation in CTNNB1, pregnancy/menopause, over-
expression of LHCGR, and primary hyperaldosteronism [31, 32]. In their opinion, based
on recently published results, pregnancy/menopause-induced primary hyperaldosteronism
cannot be directly linked with somatic mutation in CTNNB1 and b-catenin activation
[32, 33].
Interestingly, the ectopic cortical cell clusters found in the adrenal medulla coexpressed
CYP11B1 and CYP11B2 and thus demonstrated amixed steroidogenic pattern characteristic
for normal zona glomerulosa and fasciculata cells. The location in the adrenal medulla may
indicate an abnormal cell differentiation and/or migration pattern. CYP11B1, expressed in
the zona fasciculata and reticularis, generates corticosterone from 11-deoxycorticosterone
and cortisol from 11-deoxycortisol. CYP11B2, in physiological conditions, is limited to the
zona glomerulosa catalyzing aldosterone biosynthesis. CYP11B1 andCYP11B2 colocalization
adjacent to glomerulosa cells is very rare and has as yet only been observed in idiopathic
hyperaldosteronism and adrenal cells in the vicinity of an APA [34]. The expression pattern
of steroidogenic enzymes enables these cells to produce both glucocorticoids and
mineralocorticoids.
AVP-stimulated cortisol synthesis via eutopic AVPR1A and ectopic AVPR2 activation in
normal adrenal glands and BMAH tissues has been described [35]. Both AVPR1A andAVPR2
have also been detected in APAs [36]. In our patient, a mild stimulatory response to AVP in
vivo was in accordance with the increased expression of AVP receptors at the mRNA level,
immunohistochemically localized in ectopic cortical cells in the medulla. We excluded intra-
adrenal AVP production and thus any autocrine or paracrine AVP effects. Additionally, no
symptoms of exaggerated stimulation of cortisol secretion due to physiological AVPR stimuli,
such as upright posture, were observed in the patient. Thus, the clinical relevance of AVP-
stimulated cortisol secretion appears minimal.
The expression ofPOMCmRNA as well as the presence of sporadic ACTH and prohormone
convertase 1/3 (a marker of neuroendocrine cells) double-positive cells in the adrenal medulla
may suggest intra-adrenal ACTH secretion, although in such a low amount that it did not
increase the circulating ACTH concentration. Furthermore, paracrine ACTH-stimulated
cortisol secretion is highly unlikely due to normally distributed, yet, typically for BMAH
[16, 24], downregulated MC2R. Additionally, the complete remission of CS after pregnancy
excludes a substantial pathogenic role of the paracrine mechanism of cortisol production due
toACTH-positivemedullary cells. In contrast to Louiset et al. [9], we did not identify ectopic or
paracrine ACTH production in the zona fasciculata–like cells of the BMAH tissues of our
patient.
3bHSD staining (purple); (C) MC2R (green) with 3bHSD-positive cells (red) of zona
fasciculata and zona reticularis (white arrows), but not with CgA (purple) in the adrenal
medulla; (D) AVPR1A (red) with CYP17 (green); and (E) AVPR2 (red) with 3bHSD (green) in
the cortical cells (white arrows) infiltrating medulla (CgA, purple). DAPI was used as
counterstaining to detect cell nuclei (blue). Scale bars, 20 mm. AVPR1A, vasopressin receptor
1A; AVPR2, vasopressin receptor 2; CC, cortical cell in the medulla; M, medulla; ZF, zona
fasciculate; ZR, zona reticularis.
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In the literature, we found 6 cases of pregnancy-induced, transient hypercortisolism
(Supplemental Table 6) [22, 23, 37–40]. Interestingly, severe hirsutism and/or acne were
observed in all patients, and significant hypokalemia was found in 5 of 7 published patients.
In vivo hCG-stimulated cortisol secretion was positive in four of five patients [23, 38, 40]. In
the nonresponding patient, only short-time stimulation with hCG was performed [23], em-
phasizing the time-dependency of the stimulatory effect. Imaging procedures were negative
for adrenal adenomas in all patients, but macronodular hyperplasia was observed in 2 pa-
tients, both after chronic adrenal stimulation (menopause in 1 patient and 8 pregnancies
within 6 years in the other patient) [38, 40]. Data from the patient with BMAHand subclinical
CS after 8 pregnancies [40], all complicated by pregnancy-induced CS, suggest the possibility
of a transition from reversible, pregnancy-induced hypercortisolism to LH/hCG-independent
BMAH. This could well be due to the repeated, pregnancy-related, LHCGR-induced, GATA4-
modulated transformation and proliferation into LHCGR-negative, hyperplastic zona
fasciculata–type cells, with an LH/hCG-independent capacity for proliferation and cortisol
secretion resulting in BMAH and subclinical CS.
In conclusion, we present a patient with reversible, somatic mutation-independent
pregnancy-induced CS due to hCG-activated LHCGR-associated mechanism. The se-
quence of events resulting in severe CS are primarily the LH/hCG-stimulated trans-
differentiation of LHCGR-positive subcapsular cells (most likely adrenal progenitors) into
glomerulosa cells and/or hyperplastic cells responding to LH/hCG stimulation with ACTH-
independent glucocorticoid, mineralocorticoid, and androgen production. Additionally, the
presence of steroidogenic ectopic cortical cells in themedulla, capable of producing all adrenal
steroids, may add to the severe clinical CS observed in these patients. Finally AVP-
stimulated cortisol secretion, acting via AVPR1A and AVPR2 receptors in the steroido-
genically active, ectopic cortical cells in themedulla, may play a role in the increased cortisol
secretion. In contrast, the presence of ACTH-positive cells in the medulla failed to increase
systemic ACTH secretion. Although paracrine stimulation of androgens in normal MC2R-
positive zona reticularis cells in the vicinity of these ACTH-positive medullary cells cannot
be excluded, a paracrine effect on cortisol secretion is highly unlikely due to the down-
regulated MC2R.
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